Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Where things stand (June 2026) CagriSema Phase 3 results have been reported
Haematological disorders: Specialist haematology management, which may include targeted therapies for myeloproliferative disorders or treatment of underlying malignancy
How DSIP Works DSIP is a small naturally occurring nonapeptide with the amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu and a molecular weight of about 849 daltons
Our team takes the time to assess your specific needs and provides personalized solutions tailored to you
hold a published patent (WO/2023/180570) that covers the in vitro method for identifying anti-senescence compounds based on detecting the binding of said compound in the presence of at least one phosphorylated amino acid in the transcription activation domain (TAD) domain of mammalian protein p53
